drug-target pharmacodynamics part 1 Flashcards

1
Q

what is a drug

A

molecules that interact with a biological system to produce a biological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the MW of drugs

A

under 600

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

are drugs endogenous

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

examples of biologics

A

antibodies and proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is drug safety dependent on

A

therapeutic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how do you make drugs safe

A

keep it between the therapeutic window from efficacy vs toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why are drugs administered

A

to achieve a biological response that alleviates the symptoms or cause of an illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is a biological process responsible for

A

producing the symptoms or causing the illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

at the molecular level what is a drug target

A

usually a biomacromolecule (enzyme, receptor, ion channel) that’s involved in the biological process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are they key intermolecular interactions that promote association between the drug and the amino acid target proteins binding site

A

hydrogen bonding, VDW or LDF, ionic/electrostatic, pi-pi bonding and dipole interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what determines the types of interactions available for drug molecules

A

the functional groups it contains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what determines physiochemical properties such as water solubility and membrane permeability

A

the functional groups present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how do drugs with non polar, aliphatic side groups bind to targets

A

short range vdw forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do drugs with aromatic side groups bind to targets

A

short range vdw forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do drugs with polar uncharged side groups bind to targets

A

midrange H-bonds

17
Q

how do drugs with positive and negatively charged side groups bind to targets

A

long range ionic

18
Q

what does the tertiary structure allow the enzyme to do

A

perform its function and maintain the integrity of the active site where catalysis is performed

19
Q

what do the amino acids that border the active site do

A

produce a particular 3D shape that maximises interactions between the enzyme and the substrate which ensure that the substrate is in the correct position

20
Q

how does the movement of the active site lower the activation energy

A

by forcing the substrate into a transition-state confirmation which is why it is catalytic

21
Q

what are the types of interactions between the amino acids that border the active site and the substrate

A

a mixture of H-bonds which are directional and specific for H-bonding groups on the substrate

and short range vdW interactions

22
Q

what is a competitive inhibitor of cox

A

flurbiprofen

23
Q

how does flurbiprofen work

A

it binds in preference to arachidonic acid and blocks prostaglandin synthesis which reduces the inflammatory response

24
Q

how do competitive inhibitors compete with substrates

A
  • must have some structural resemblance so that it can match the 3D shape of the active site
  • must form stronger interactions with the active site so that it binds in preference to the substrate
  • need to stay in longer than the substrate as usually the binding process is dynamic and molecules will associate and dissociate
25
Q

what type of interactions happen between the enzymes that border the active site and an inhibtor/drug

A

the same as the interactions between the substrate and the active site

26
Q
A